OR-48
BNP ENHANCES RENAL ACTIONS OF LASIX AND
SUPPRESSES LASIX-INDUCED ALDOSTERONE
ACTIVATION IN EXPERIMENTAL HEART FAILURE
Alessandro Cataliotti, Guido Boerrigter, Lisa C Costello-Boerrigter,
Toshihiro Tsuruda, John A Schirger, Horng H Chen,
Lorenzo S Malatino, John C Burnett Jr. Cardiorenal Research
Laboratory, Mayo Clinic and Foundation, Rochester, MN.
Congestive heart failure (CHF) is characterized by sodium and water
retention. While loop diuretics are powerful natriuretic agents, they can
reduce glomerular filtration rate (GFR) and activate the renin-angioten-
sin-aldosterone system (RAAS). Studies have reported that GFR is a key
predictor of mortality in CHF. Therefore, new therapeutic strategies are
warranted to both minimize side effects of conventional diuretics and to
potentiate their renal actions. Brain natriuretic peptide (BNP) has di-
uretic, natriuretic and renin and aldosterone inhibiting properties. The
renal actions of BNP in CHF are associated with preserved GFR without
activation of RAAS. The objective of this study was to test the hypothesis
that BNP potentiates the renal actions of Lasix (L) in a model of CHF.
We hypothesized that BNP in combination with L maintains GFR and
suppresses the RAAS. CHF was produced in two groups of dogs by rapid
ventricular pacing (10 days at 240 bpm). At day 11 one group received
continuous (60 min) iv administered L (1mg/Kg/hr). A second group
(BNP+L) received 30 min iv co-infusion of L (1mg/Kg/hr) and low dose
(2 pmol/kg/min) of BNP followed by 30 min co-infusion of L (1mg/Kg/
hr) and high dose (10 pmol/kg/min) of BNP. * indicates p0.05 vs
baseline. There were no differences in cardiovascular hemodynamics
between groups. L increased urinary flow (from baseline 0.78 0.05 to
5.01.06* mL/min), but the effect of BNP+L was significantly
(p0.0021) higher (from 0.46 0.03 to 8.041.21* low and
7.390.94* high dose mL/min). Similarly, urinary sodium excretion (L:
from 74.89141.71 to 614.0323.13* mEq/min; BNP+L: from
39.4175.9 to 988.16282.12* low and 950.93299.37* high dose
mEq/min) was significantly higher in BNP+L group (p0.0025). While
GFR tended to decrease in L group, it increased in BNP+L group
(p=0.006). Plasma aldosterone increased with L but remained preserved
in BNP+L group(p0.05). L and the BNP+L had similar beneficial
cardiovascular hemodynamic actions. Importantly, with a profound na-
triuretic and diuretic response with BNP+L, GFR was increased with no
activation of aldosterone. Co-administration of BNP and loop diuretic
may be beneficial in preserving renal function and inhibiting activation of
aldosterone while maximizing natriuresis and diuresis.
Key Words: BNP, Lasix, Heart Failure
OR-49
INCREASED PLASMA ENDOTHELIN-1 AND
IMPAIRED VASORELAXATION IN MICE FEATURING
ENDOTHELIAL CELL SPECIFIC KNOCKOUT OF THE
ENDOTHELIN B RECEPTOR
Alan J Bagnall, Fiona Gulliver-Sloan, Kelland F Nick,
Yanagisawa Masashi, David J Webb, Kotelevtsev Yuri. Centre for
Cardiovascular Science, University of Edinburgh, Edinburgh, Mid
Lothian, United Kingdom; Department of Molecular Genetics,
University of Texas Southwestern Medical Center, Dallas.
The role of the murine endothelial cell (EC) endothelin B receptor
(ETBR) in vascular function and BP regulation was investigated.
Floxed ETBR mice with loxP sites flanking exons 2 and 3 were
generated through homologous recombination in embryonic stem cells.
Flox/Wild (F/W) mice were crossed with Tie2-Cre transgenic mice to
produce EC-specific ETBR knockout mice (KO) (F/F Tie2). Wild type
(W/W -/-) and single transgenic (W/W Tie2 and F/F -/-) littermates acted
as controls. In vitro vascular function was assessed by wire myography
and in vivo BP is being measured in conscious animals using i.a.
catheters. 125I ET-1 binding was measured in pulmonary EC. Plasma
ET-1 was measured by RIA.
Aortic rings of F/F Tie2 mice exhibit impaired vasodilation to the
selective ETBR agonist Sarafotoxin 6c (Sx6c; see fig) and to acetylcho-
line (ACh; logEC50 SEM: F/F Tie2, 6.76 0.08; W/W -/- 7.06
0.10; W/W Tie2 7.09 0.07; F/F -/- 7.02 0.12; p0.0001 for all
groups; n = 16 in each group). There was no difference in Sx6c-mediated
contraction of tracheal rings (non-EC control) from F/F Tie2 animals
compared to controls. 125I ET-1 binding in pulmonary EC was down by
85% and plasma ET-1 increased in EC ETBR knockout mice (see fig).
Preliminary data shows that BP is not elevated in the absence of sodium
loading.
We have successfully achieved EC-specific knockout of the ETBR in
the mouse. This model has an impaired vasodilator response to Sx6c and
ACh but maintains normal tracheal smooth muscle ETBR-mediated
contraction. The mechanism underlying the impaired ACh response
awaits further investigation. The EC ETBR is likely to represent the
clearance receptor for circulating ET-1. The floxed ETBR KO mouse will
be a useful tool for the study of the role of EC ETBR in cardiovascular
function.
Key Words: Endothelin, ETB receptor, Cre recombinase
OR-50
DIETARY SALT REGULATES RENAL
AMINOPEPTIDASE N ABUNDANCE: GENETIC AND
TRANSCRIPTIONAL EVIDENCE FOR
AMINOPEPTIDASE N AS A CANDIDATE GENE IN
THE DAHL SALT-SENSITIVE RAT
Theressia L. Washington, Mariam Farjah, Bryan P. Roxas,
Robert S. Danziger. Cardiology/Internal Medicine, University of
Illinois, Chicago, IL; West Side Veterans Administration, Chicago, IL.
Purpose: Aminopeptidase N (APN), known also as microsomal amino-
peptidase, is a major constitutent of the brush border membranes of
kidney proximal tubule cells. The enzyme releases neutral amino acids
from oligopeptides and converts angiotensin III to angiotensin IV. The
present study was undertaken to determine whether it plays a role in the
regulation of renal salt-handling and the pathogenesis of salt-sensitive
hyperension.
Methods: Renal APN transcript abundance was measured, using
SYBR Green reverse transcription coupled with the polymerase chain
reaction (RT/PCR), in Sprague Dawley (SD) and Dahl salt-sensitive (SS)
rats on either 8% (high) or 0.3% (basal) NaCl diets for 10 days. The APN
gene was mapped with respect to known quantitative trait loci (QTL)
using radiation-hybrid mapping and available mapping data. Meprin
cDNA sequences were determined in both Sprague Dawley and Dahl
SS/Jr rat strains using dedeoxy sequencing.
22A AJH–May 2003–VOL. 16, NO. 5, PART 2 ORALS: Vasoactive Hormones/Endothelial Factors
0895-7061/03/$30.00 © 2003 by the American Journal of Hypertension, Ltd.
Published by Elsevier Inc.
Downloaded from https://academic.oup.com/ajh/article/16/S1/22A/194466 by guest on 23 November 2023